LDV Partners

Laidlaw Venture Partners (LVP) is the venture capital arm of Laidlaw & Company, focusing on early to growth-stage investments, particularly in healthcare and biotechnology. Based in New York, LVP leverages Laidlaw’s extensive network and infrastructure to provide strategic guidance and capital to innovative startups. The firm’s investment approach is unique in that it combines venture capital expertise with access to a fully licensed broker-dealer, enabling it to offer comprehensive support, including capital formation and market strategies. LVP’s portfolio includes companies across various healthcare sectors, from biotechnology to medical devices. The firm is known for its hands-on approach, providing not only funding but also operational support through a team of seasoned advisors. Recent strategic additions like Dr. Zachary Shriver and Dr. George Steinfels have enhanced LVP’s capacity to guide portfolio companies, particularly in clinical development and manufacturing, which are critical for biotech startups. With a robust track record in investment banking and venture formation, LVP continues to back companies that are poised for substantial growth. The firm’s connection with Laidlaw & Company allows it to offer broader financial services and more significant investor alignment, making it a valuable partner for companies looking to scale and navigate complex regulatory environments.